Why Hinge Health's 52% Growth Stock Is Surging Again

Hinge Health Surpasses Expectations in Its First Quarter as a Publicly Traded Company

Hinge Health (HNGE) made a strong debut on the stock market, reaching a record high on Wednesday following impressive results from its first quarter as a publicly traded company. The company's performance exceeded expectations across multiple financial metrics, signaling a promising future for the AI-powered physical therapy platform.

During the second quarter, Hinge Health reported sales of $139.1 million, surpassing the expected $125.4 million according to FactSet. This represents a 55% year-over-year growth, highlighting the company's strong market position and increasing demand for its services. In addition to revenue, the company generated $32.6 million in free cash flow, significantly exceeding the projected $20.3 million.

Strong Financial Performance and Analyst Confidence

KeyBanc Capital Markets analyst Scott Schoenhaus praised Hinge Health’s performance, noting that the company outperformed even his highest expectations. He highlighted the 55% growth in billings and revenue, along with operating margins nearing 20%. Schoenhaus raised his price target for Hinge Health from $60 to $70, reflecting confidence in the company’s long-term potential.

The stock surged 25.6% to $60.55, hitting a new all-time high. Since its initial public offering (IPO) in May, shares have climbed approximately 52% from their initial offering price of $32, as of Tuesday's close. This significant increase underscores investor optimism about the company's future growth.

Expanding Client Base and Market Position

Hinge Health’s success is also reflected in its growing client base. During the second quarter, the company served 2,359 clients, a 32% increase compared to the same period last year. CEO Daniel Perez emphasized that the company’s AI-powered platform is gaining traction in the healthcare industry, despite the challenges of automating care delivery.

Schoenhaus also pointed out that earnings before interest and taxes (EBIT) reached $26.1 million, which was six times higher than what analysts had anticipated. This strong performance has led the company to raise its third-quarter sales guidance to between $141 million and $143 million, up 41% at the midpoint. Analysts had previously forecasted only $128.8 million in sales for the quarter.

In addition, Hinge Health expects EBIT to range between $17 million and $21 million for the third quarter, far exceeding the estimated $5.1 million from analysts. For the full year, the company projects sales of $548 million to $552 million, surpassing the $511.3 million estimate. Adjusted EBIT is expected to be between $77 million and $83 million, roughly double the analysts' forecast of $40 million.

Valuation and Market Comparison

Despite its strong performance, Hinge Health currently trades at a lower valuation multiple compared to market leaders in the digital health sector. Veeva Systems (VEEV) and Doximity (DOCS) trade at 13 times and 16.5 times forward revenue expectations, respectively. Even after Wednesday's rally, Hinge Health’s stock trades at 7.5 times fiscal year 2026 forecasts.

Schoenhaus believes that this valuation gap will narrow over the next few quarters as Hinge Health continues to outperform and analyst estimates rise. He noted that the company’s financial metrics are becoming increasingly comparable to those of market leaders.

Strong Investor Sentiment and Performance Metrics

Hinge Health also benefits from strong investor sentiment, as evidenced by its IBD Digital Relative Strength Rating of 88. This rating places the stock in the top 12% of all stocks based on 12-month performance, indicating robust momentum and investor confidence.

As the company continues to grow and expand its offerings, it is well-positioned to capitalize on the increasing demand for digital health solutions. With strong financials, a growing client base, and a compelling valuation story, Hinge Health is emerging as a key player in the evolving healthcare technology landscape.